Last reviewed · How we verify

NCT05401851: LBBAP

Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a Comparison Study

Status unknown NA Last updated 28 February 2024
What this trial tests

NA trial testing Left Bundel Area Pacing in Bradyarrhythmia in 30 participants. Status unknown.

Timeline
24 March 2022
Primary endpoint
21 February 2024
21 October 2024

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date24 March 2022
Primary completion21 February 2024
Estimated completion21 October 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

18 and older, any sex, with Bradyarrhythmia or Pacemaker Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study of the ventricular activation patterns during left bundle area pacing and compare it with baseline activation during normal sinus rhythm in patients with and without baseline bundle branch conduction disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bradyarrhythmia

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05401851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing